Paradigm Biocapital Advisors LP - 23 Jul 2025 SCHEDULE 13G Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
CDTX
Shares outstanding
20,153,804 shares
Disclosed Ownership
1,128,613 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
30 Jul 2025, 16:14:23 UTC
Date of event
23 Jul 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Paradigm Biocapital Advisors LP disclosed 5.6% ownership in Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX) on 23 Jul 2025."

Quick Takeaways

  • Paradigm Biocapital Advisors LP filed SCHEDULE 13G for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX).
  • Disclosed ownership: 5.6%.
  • Date of event: 23 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Jul 2025, 16:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5.6% 1,128,613 1,128,613 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5.6% 1,128,613 1,128,613 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5.6% 1,128,613 1,128,613 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.9% 994,177 994,177 0 /s/ David K. Kim David K. Kim / Authorized Signatory

Sponsored